WHV Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$3.41M Sell
30,329
-498,169
-94% -$51.8M 1.83% 23
2015
Q4
$57.5M Sell
528,498
-197,747
-27% -$22.6M 2.54% 18
2015
Q3
$83.3M Sell
726,245
-61,335
-8% -$6.67M 2.3% 18
2015
Q2
$89.8M Sell
787,580
-79,396
-9% -$9.63M 2.01% 20
2015
Q1
$90.6M Sell
866,976
-68,123
-7% -$7.26M 1.78% 21
2014
Q4
$113M Sell
935,099
-64,943
-6% -$8.53M 1.93% 19
2014
Q3
$146M Sell
1,000,042
-41,222
-4% -$6.36M 2.09% 20
2014
Q2
$174M Sell
1,041,264
-31,046
-3% -$5.52M 2.19% 21
2014
Q1
$213M Sell
1,072,310
-133,105
-11% -$25.1M 2.79% 17
2013
Q4
$230M Sell
1,205,415
-142,117
-11% -$26.4M 2.4% 15
2013
Q3
$228M Sell
1,347,532
-102,133
-7% -$15.9M 2.26% 17
2013
Q2
$220M Buy
+1,449,665
New +$205M 2.26% 18

Other funds holding CLB

WHV Investments's CLB Position: Q1 2016 in Review

WHV Investments reduced its Core Laboratories (CLB) stake by 94% in Q1 2016, selling an estimated $51.8M and leaving 30,329 shares worth $3.41M. The position accounts for 1.83% of the portfolio, ranked #23.

WHV Investments first reported a position in CLB in Q2 2013 and has held it in 12 quarters since. The position peaked at $230M in Q4 2013. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

  • WHV Investments held 30,329 shares of Core Laboratories worth $3.41M as of Q1 2016.
  • WHV Investments sold 498,169 Core Laboratories shares in Q1 2016, an estimated $51.8M.
  • Core Laboratories made up 1.83% of WHV Investments's portfolio in Q1 2016, its #23 holding.
  • WHV Investments first reported a position in Core Laboratories in Q2 2013 and has held it in 12 quarters since.
  • WHV Investments's Core Laboratories position peaked at $230M in Q4 2013.
  • 365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on WHV Investments's 13F filing for Q1 2016, filed 11 May 2016.